| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 113.050 | 100.425 | 97.089 | 103.403 | 110.564 | 120.902 | 130.604 | 128.907 | 137.494 | 134.917 |
| Total Income - EUR | 122.492 | 100.764 | 97.211 | 103.473 | 110.857 | 121.074 | 130.606 | 130.023 | 137.496 | 134.919 |
| Total Expenses - EUR | 105.429 | 90.488 | 88.457 | 97.208 | 99.730 | 108.681 | 114.979 | 117.452 | 128.336 | 123.932 |
| Gross Profit/Loss - EUR | 17.063 | 10.276 | 8.754 | 6.265 | 11.127 | 12.392 | 15.627 | 12.571 | 9.160 | 10.987 |
| Net Profit/Loss - EUR | 13.891 | 8.920 | 7.782 | 5.230 | 10.016 | 11.449 | 14.345 | 11.280 | 7.942 | 9.338 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Farmacia Cardio Lavidena Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.265 | 2.374 | 1.224 | 943 | 1.053 | 712 | 432 | 169 | 1.356 | 747 |
| Current Assets | 56.219 | 42.483 | 42.443 | 34.557 | 27.602 | 35.544 | 43.116 | 43.734 | 40.939 | 36.362 |
| Inventories | 32.413 | 31.973 | 25.355 | 16.643 | 10.993 | 15.948 | 18.898 | 16.112 | 17.795 | 15.322 |
| Receivables | 17.647 | 3.620 | 15.462 | 16.730 | 14.954 | 19.054 | 22.898 | 22.851 | 20.130 | 18.779 |
| Cash | 6.159 | 6.890 | 1.627 | 1.184 | 1.656 | 541 | 1.273 | 4.772 | 3.014 | 2.262 |
| Shareholders Funds | 58.083 | 14.860 | 13.635 | 18.615 | 26.051 | 32.666 | 19.890 | 11.380 | 19.288 | 13.259 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.401 | 29.996 | 30.033 | 16.886 | 2.604 | 3.590 | 23.658 | 32.523 | 23.008 | 23.850 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacia Cardio Lavidena Srl